← 返回

淋巴结仿生支架增强 CAR-T 疗法抗实体瘤效果

英文原题:Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor.

查看英文原题

Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor.

PubMed 2024/01/11(内容时间) Natl Sci Rev Q1 · IF 18.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

有限的浸润和持久性是嵌合抗原受体 (CAR)-T 细胞在实体瘤中疗效不足的主要原因。在此,我们提出一种三维支架,其灵感来源于淋巴结中 T 细胞增殖的生理过程。该支架集成了负载、递送、激活和扩增 CAR-T 细胞的功能,以增强其对实体瘤的治疗效果。这种多孔装置由聚乳酸-羟基乙酸共聚物通过微流控技术制成,并修饰了 T 细胞刺激信号,包括 anti-CD3、anti-CD28 抗体以及细胞因子。该支架在体外促进 CAR-T 细胞扩增 50 倍,在体内促进细胞扩增 15 倍。特别是,在宫颈肿瘤模型中,它能维持 CAR-T 细胞的持久扩增长达 30 天,并显著抑制肿瘤生长。这种仿生递送策略为 CAR-T 细胞治疗实体瘤提供了一种多功能的细胞递送和激活平台。

展开英文摘要原文

The limited infiltration and persistence of chimeric antigen receptor (CAR)-T cells is primarily responsible for their treatment deficits in solid tumors.

Here, we present a three-dimensional scaffold, inspired by the physiological process of T-cell proliferation in lymph nodes. This scaffold gathers the function of loading, delivery, activation and expansion for CAR-T cells to enhance their therapeutic effects on solid tumors. This porous device is made from poly(lactic-co-glycolic acid) by a microfluidic technique with the modification of T-cell stimulatory signals, including anti-CD3, anti-CD28 antibodies, as well as cytokines.

This scaffold fosters a 50-fold CAR-T cell expansion in vitro and a 15-fold cell expansion in vivo . Particularly, it maintains long-lasting expansion of CAR-T cells for up to 30 days in a cervical tumor model and significantly inhibits the tumor growth. This biomimetic delivery strategy provides a versatile platform of cell delivery and activation for CAR-T cells in treating solid tumors.

论文信息

作者
Liao Z、Jiang J、Wu W、Shi J、Wang Y、Yao Y、Sheng T、Liu F
单位
National Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.China
期刊
National science review2024 Apr
原文标识
PubMed 38440217 · DOI 10.1093/nsr/nwae018